PIK3CA and neoplasm: The proportion of patients with high pAKT activity was similar in tumours harbouring pathogenic alterations of any member of the PIK3CA pathway compared to wild-type tumours (79% versus 77%, respectively; p > 0.05) (Fig. 3a).